Scinai Immunotherapeutics (SCNI) Free Cash Flow (2018 - 2026)
Scinai Immunotherapeutics (SCNI) reported Free Cash Flow of -$1.5 million for Q1 2026, down 40.79% on a YoY basis from -$2.5 million in Q1 2025, and up 5.09% sequentially from -$1.5 million in Q2 2025.
Scinai Immunotherapeutics (SCNI) Free Cash Flow (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Free Cash Flow data on file, last reported at -$1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 40.79% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$4.0 million (up 32.14% YoY), and the FY2025 full-year result was -$6.1 million, up 4.6% from the prior year.
- Free Cash Flow rose to -$1.5 million in Q1 2026, from -$1.5 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.0 million in Q1 2025 to a low of -$3.6 million in Q2 2022.
- A 5-year average of -$2.0 million and a median of -$1.8 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow jumped 70.53% in 2022 and tumbled 87.76% in 2023, its largest moves.
- Tracing SCNI's Free Cash Flow over 5 years: stood at -$2.0 million in 2022, then dropped by 13.53% to -$2.3 million in 2023, then jumped by 51.43% to -$1.1 million in 2024, then plunged by 39.18% to -$1.5 million in 2025, then gained by 5.09% to -$1.5 million in 2026.
- Business Quant data shows SCNI's Free Cash Flow at -$1.5 million in Q1 2026, -$1.5 million in Q2 2025, and -$1.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.45 Mn |
| Mar 31, 2026 | -1.45 Mn |
| Jun 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -1.53 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -1.75 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Dec 31, 2023 | -2.27 Mn |
| Dec 31, 2023 | -2.27 Mn |
| Sep 30, 2023 | -2.20 Mn |
| Sep 30, 2023 | -2.20 Mn |
| Jun 30, 2023 | -2.50 Mn |
| Jun 30, 2023 | -2.50 Mn |